Date:2/24/2012

to the protection of Abaxis' intellectual property or claims of infringement of intellectual property asserted by third parties, risks related to condition of the United States economy and other risks detailed under "Risk Factors" in Abaxis' Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2011 and Abaxis' other periodic reports filed from time to time with the United States Securities and Exchange Commission.  Forward-looking statements speak only as of the date the statements were made.  Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements. Contact:

Clint Severson

Lytham Partners, LLC 

Chief Executive Officer

Joe Dorame, Joe Diaz & Robert Blum 

ABAXIS, Inc.

602-889-9700 

510-675-6500

  

'/>"/>

SOURCE Abaxis, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Abaxis, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
2. Abaxis, Inc. to Present at Stephens, Inc. 2011 Fall Investment Conference
3. Abaxis, Inc. to Present at Sidoti & Companys New York II Emerging Growth Institutional Investor Forum
4. Abaxis, Inc. to Present at CL Kings 9th Annual Best Ideas Conference 2011
5. Abaxis, Inc. Awarded $650,000 from Kansas Bioscience Authority
6. Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
7. Abaxis, Inc. to Present at the 10th Annual Needham Healthcare Conference
8. Abaxis, Inc. to Present at RBC Capital Markets Healthcare Conference
9. Abaxis, Inc. to Present at Stephens Fall Investment Conference
10. Abaxis, Inc. to Present at Sidoti & Companys Ninth Annual West Coast Institutional Investor Forum
11. Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference